118 related articles for article (PubMed ID: 34139190)
1. Role of Soluble Receptor for Advanced Glycation End Products in Postoperative Fibrotic Lung Injury.
Nakao S; Yamaguchi K; Iwamoto H; Kagimoto A; Mimae T; Tsutani Y; Miyata Y; Hamada H; Okada M; Hattori N
Ann Thorac Surg; 2022 May; 113(5):1617-1623. PubMed ID: 34139190
[TBL] [Abstract][Full Text] [Related]
2. Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease.
Nakao S; Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Respir Med; 2020 Oct; 172():106131. PubMed ID: 32911136
[TBL] [Abstract][Full Text] [Related]
3. Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients.
Yamaguchi K; Nakao S; Iwamoto H; Kagimoto A; Handa Y; Sakamoto S; Horimasu Y; Masuda T; Mimae T; Miyamoto S; Nakashima T; Tsutani Y; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
Sci Rep; 2021 May; 11(1):10105. PubMed ID: 33980944
[TBL] [Abstract][Full Text] [Related]
4. Associations between Comorbidities and Acute Exacerbation of Interstitial Lung Disease after Primary Lung Cancer Surgery.
Kato T; Miyoshi S; Hamada C; Sano Y; Nogami N; Yamaguchi O; Hamaguchi N
Acta Med Okayama; 2023 Jun; 77(3):301-309. PubMed ID: 37357631
[TBL] [Abstract][Full Text] [Related]
5. Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer.
Kagimoto A; Tsutani Y; Kushitani K; Kambara T; Mimae T; Miyata Y; Takeshima Y; Okada M
BMC Pulm Med; 2021 Jun; 21(1):186. PubMed ID: 34078355
[TBL] [Abstract][Full Text] [Related]
6. Associations of high-mobility group box 1 and receptor for advanced glycation end products with acute lung injury in patient with acute aortic dissection.
Zeng Z; Zhang K; Cai J; Wu H; Yue J
Rev Assoc Med Bras (1992); 2021 Sep; 67(9):1251-1255. PubMed ID: 34816916
[TBL] [Abstract][Full Text] [Related]
7. Association between glucose intolerance and chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease.
Otani T; Yamaguchi K; Nakao S; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Hattori N
Cancer Chemother Pharmacol; 2021 Nov; 88(5):857-865. PubMed ID: 34350479
[TBL] [Abstract][Full Text] [Related]
8. Predicting Severe Postoperative Complication in Patients With Lung Cancer and Interstitial Pneumonia.
Ohsawa M; Tsutani Y; Fujiwara M; Mimae T; Miyata Y; Okada M
Ann Thorac Surg; 2020 Apr; 109(4):1054-1060. PubMed ID: 31887276
[TBL] [Abstract][Full Text] [Related]
9. Outcome and prognosis of secondary lung cancer surgery with interstitial lung disease.
Ichinokawa H; Takamochi K; Fukui M; Hattori A; Matsunaga T; Suzuki K
Thorac Cancer; 2022 Jul; 13(14):2024-2030. PubMed ID: 35637601
[TBL] [Abstract][Full Text] [Related]
10. Association between intraoperative ventilator settings and plasma levels of soluble receptor for advanced glycation end-products in patients without pre-existing lung injury.
Jabaudon M; Futier E; Roszyk L; Sapin V; Pereira B; Constantin JM
Respirology; 2015 Oct; 20(7):1131-8. PubMed ID: 26122046
[TBL] [Abstract][Full Text] [Related]
11. [Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease].
Huang C; Ma C; Wu Q; Jiao P; Sun Y; Tian W; Yu H; Huang W; Wang Y; Tong H
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):343-350. PubMed ID: 32429636
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of
Akaike K; Saruwatari K; Oda S; Shiraishi S; Takahashi H; Hamada S; Iyama S; Horio Y; Tomita Y; Saeki S; Okamoto S; Ichiyasu H; Fujii K; Sakagami T
Int J Clin Oncol; 2020 Apr; 25(4):681-690. PubMed ID: 31781994
[TBL] [Abstract][Full Text] [Related]
13. What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection?
Miyajima M; Watanabe A; Sato T; Teramukai S; Ebina M; Kishi K; Sugiyama Y; Kondo H; Kobayashi S; Takahashi Y; Ito H; Yamamoto R; Sawada S; Fujimori H; Okabe K; Arikura J; Shintani Y; Nakamura H; Toyooka S; Hasumi T; Watanabe T; Hata Y; Iwata H; Aoki M; Funai K; Inoue S; Kawashima O; Iida T; Date H
Surg Today; 2018 Apr; 48(4):404-415. PubMed ID: 29124429
[TBL] [Abstract][Full Text] [Related]
14. Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.
Smit PJ; Guo WA; Davidson BA; Mullan BA; Helinski JD; Knight PR
J Surg Res; 2014 Sep; 191(1):214-23. PubMed ID: 24814199
[TBL] [Abstract][Full Text] [Related]
15. Soluble isoform of the receptor for advanced glycation end products as a biomarker for postoperative respiratory failure after cardiac surgery.
Uchida T; Ohno N; Asahara M; Yamada Y; Yamaguchi O; Tomita M; Makita K
PLoS One; 2013; 8(7):e70200. PubMed ID: 23894617
[TBL] [Abstract][Full Text] [Related]
16. Importance of Lung Epithelial Injury in COVID-19-associated Acute Respiratory Distress Syndrome: Value of Plasma Soluble Receptor for Advanced Glycation End-Products.
Kapandji N; Yvin E; Devriese M; de Margerie-Mellon C; Moratelli G; Lemiale V; Jabaudon M; Azoulay E; Constantin JM; Dumas G
Am J Respir Crit Care Med; 2021 Aug; 204(3):359-362. PubMed ID: 34033529
[No Abstract] [Full Text] [Related]
17. Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control study.
Nakamura K; Kato M; Shukuya T; Mori K; Sekimoto Y; Ihara H; Kanemaru R; Ko R; Shibayama R; Tajima K; Koyama R; Shimada N; Nagashima O; Takahashi F; Sasaki S; Takahashi K
BMC Cancer; 2017 May; 17(1):302. PubMed ID: 28464801
[TBL] [Abstract][Full Text] [Related]
18. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer.
Masuda T; Hirano C; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Cancer Chemother Pharmacol; 2018 Jan; 81(1):131-139. PubMed ID: 29143072
[TBL] [Abstract][Full Text] [Related]
19. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer.
Sato T; Teramukai S; Kondo H; Watanabe A; Ebina M; Kishi K; Fujii Y; Mitsudomi T; Yoshimura M; Maniwa T; Suzuki K; Kataoka K; Sugiyama Y; Kondo T; Date H;
J Thorac Cardiovasc Surg; 2014 May; 147(5):1604-1611.e3. PubMed ID: 24267779
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival after complete resection of non-small-cell lung cancer in patients with interstitial lung disease.
Sekihara K; Aokage K; Oki T; Omori T; Katsumata S; Ueda T; Miyoshi T; Goto M; Nakasone S; Ichikawa T; Hishida T; Yoshida J; Hisakane K; Goto K; Tsuboi M
Interact Cardiovasc Thorac Surg; 2018 Apr; 26(4):638-643. PubMed ID: 29272403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
